
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP)
Ludger Klimek, Ulrike Förster‐Ruhrmann, Achim Beule, et al.
Allergo Journal International (2022) Vol. 31, Iss. 6, pp. 149-160
Open Access | Times Cited: 14
Ludger Klimek, Ulrike Förster‐Ruhrmann, Achim Beule, et al.
Allergo Journal International (2022) Vol. 31, Iss. 6, pp. 149-160
Open Access | Times Cited: 14
Showing 14 citing articles:
Type 2 immunity in allergic diseases
İsmail Öğülür, Yasutaka Mitamura, Duygu Yazıcı, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 6
İsmail Öğülür, Yasutaka Mitamura, Duygu Yazıcı, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 6
Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia
F Fujieda, Chenwei Wang, Mamoru Yoshikawa, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 10
F Fujieda, Chenwei Wang, Mamoru Yoshikawa, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 10
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy
Claus Bachert, Amber Luong, Philippe Gevaert, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2630-2641
Open Access | Times Cited: 21
Claus Bachert, Amber Luong, Philippe Gevaert, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2630-2641
Open Access | Times Cited: 21
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up
Martin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 1, pp. 18-31
Open Access | Times Cited: 16
Martin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 1, pp. 18-31
Open Access | Times Cited: 16
Verschiedene immunologische Typen der CRSwNP im Kontext der neuen Europäischen EAACI-Nomenklatur
L. Klimek, S. Becker, Boris Haxel, et al.
HNO (2025)
Open Access
L. Klimek, S. Becker, Boris Haxel, et al.
HNO (2025)
Open Access
Raccomandazioni pratiche nella gestione ambulatoriale della rinosinusite cronica con poliposi nasale severa, nell’era dei biologici
Eugenio De Corso, Carlotta Pipolo, Elena Cantone, et al.
Acta Otorhinolaryngologica Italica (2023) Vol. 43, Iss. 5, pp. 324-340
Open Access | Times Cited: 10
Eugenio De Corso, Carlotta Pipolo, Elena Cantone, et al.
Acta Otorhinolaryngologica Italica (2023) Vol. 43, Iss. 5, pp. 324-340
Open Access | Times Cited: 10
Current goals of NSAID-ERD management: patient-centered approaches involving NSAID desensitization with and without biologics
Irina Bobolea, Jan Hagemann, Marek Sanak, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2934-2944
Open Access | Times Cited: 2
Irina Bobolea, Jan Hagemann, Marek Sanak, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2934-2944
Open Access | Times Cited: 2
COVID-19 and chronic rhinosinusitis: management and comorbidity – what have we learned?
Ludger Klimek, Jan Hagemann, Tilman Huppertz, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 11, pp. 1399-1406
Closed Access | Times Cited: 4
Ludger Klimek, Jan Hagemann, Tilman Huppertz, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 11, pp. 1399-1406
Closed Access | Times Cited: 4
Evaluation of ongoing mepolizumab treatment in chronic rhinosinusitis with nasal polyps
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
(2024), pp. 33-48
Open Access | Times Cited: 1
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
(2024), pp. 33-48
Open Access | Times Cited: 1
Empfehlungen zur Überprüfung der Wirksamkeit und Verlaufsdokumentation von Dupilumab bei chronischer Rhinosinusitis mit Nasenpolypen (CRSwNP) im deutschen Gesundheitssystem
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Laryngo-Rhino-Otologie (2022) Vol. 101, Iss. 11, pp. 855-865
Open Access | Times Cited: 7
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Laryngo-Rhino-Otologie (2022) Vol. 101, Iss. 11, pp. 855-865
Open Access | Times Cited: 7
Empfehlungen zur Überprüfung der Wirksamkeit und Verlaufsdokumentation von Mepolizumab bei chronischer Rhinosinusitis mit Nasenpolypen (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Laryngo-Rhino-Otologie (2023) Vol. 102, Iss. 02, pp. 89-99
Closed Access | Times Cited: 3
Ludger Klimek, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Laryngo-Rhino-Otologie (2023) Vol. 102, Iss. 02, pp. 89-99
Closed Access | Times Cited: 3
Hat die ASS-Desaktivierung in Zeiten von Biologika noch einen Stellenwert bei chronischer Rhinosinusitis mit nasaler Polyposis?
Felix Klimek, Ulrike Förster‐Ruhrmann, Jan Hagemann, et al.
HNO (2024) Vol. 72, Iss. 7, pp. 484-493
Closed Access
Felix Klimek, Ulrike Förster‐Ruhrmann, Jan Hagemann, et al.
HNO (2024) Vol. 72, Iss. 7, pp. 484-493
Closed Access
Mythos Nr. 2 „Eines für alle?“ - über die Wahl des richtigen Biologikums
Ludger Klimek, Sven Becker, Caroline Beutner, et al.
Allergo Journal (2024) Vol. 33, Iss. 5, pp. 40-43
Closed Access
Ludger Klimek, Sven Becker, Caroline Beutner, et al.
Allergo Journal (2024) Vol. 33, Iss. 5, pp. 40-43
Closed Access
Positionspapier: ICD-Codierung der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) im ICD-10-GM als Grundlage für eine Therapie mit Biologika
Sven Becker, Martin Laudien, Ulrike Förster‐Ruhrmann, et al.
Laryngo-Rhino-Otologie (2023) Vol. 102, Iss. 05, pp. 349-356
Closed Access | Times Cited: 1
Sven Becker, Martin Laudien, Ulrike Förster‐Ruhrmann, et al.
Laryngo-Rhino-Otologie (2023) Vol. 102, Iss. 05, pp. 349-356
Closed Access | Times Cited: 1